Patent ID: 7976862

Claim:
An ocular implantable sustained release bioactive agent delivery device comprising: (a) a coil-shaped body member formed of a material that has a cross-section of 1 mm or less, the body member having a direction of extension, a longitudinal axis along the direction of extension, and a proximal end and a distal end, wherein at least a portion of the body member deviates from the direction of extension, and wherein the body member has a length from its proximal end to its distal end of 1 cm or less; and (b) a polymeric coated composition in contact with a surface of the body member, the polymeric coated composition comprising a first polymer, a second polymer, and a bioactive agent, wherein the first polymer comprises polyalkyl(meth)acrylate, and wherein the second polymer comprises poly(ethylene-co-vinyl acetate), wherein the polymeric coated composition is formulated to release less than 50 weight percent of the total quantity of the bioactive agent within an initial 24 hours after introduction of the device into a patient's eye, and wherein the bioactive agent is present in an amount in the range of 1 μg to 10 mg of bioactive agent per cm 2 of the coated surface of the device.